BIO-TECHNE Corp (TECH) stock

TECHNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30

Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q/A on Nov 12, 2026Score 11/3040% above fair value

$72.80−0.04 (-0.05%)

Close on Nov 13, 2026Market cap $11.43BP/E 66.8Yield 0.44%

Bio-Techne price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Bio-Techne's price to sales ratio was 9.4× on Nov 11, 2026, against 8.3× a year earlier. Over the last 5 years it ranged from 6.3× to 20.6×, with a median of 10.0×.

Price to Sales Ratio at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	9.4×	+1.8
2025	Dec 31, 2025	7.5×	−2.2
2024	Dec 31, 2024	9.8×	−0.9
2023	Dec 29, 2023	10.7×	−1.0
2022	Dec 30, 2022	11.6×	−9.0
2021	Dec 31, 2021	20.6×	+4.5
2020	Dec 31, 2020	16.1×	+4.8
2019	Dec 31, 2019	11.4×	+3.1
2018	Dec 31, 2018	8.3×	−0.1
2017	Dec 29, 2017	8.4×	+1.0
2016	Dec 30, 2016	7.4×	+0.1
2015	Dec 31, 2015	7.3×	−1.7
2014	Dec 31, 2014	9.0×	−1.9
2013	Dec 31, 2013	10.9×	+2.8
2012	Dec 31, 2012	8.1×	−0.4
2011	Dec 30, 2011	8.4×	−0.6
2010	Dec 31, 2010	9.0×	−0.8
2009	Dec 31, 2009	9.8×	–